Recent Episodes
What’s New in Chronic Lymphocytic Leukemia (CLL)?
Kerry A. Rogers, MD, The Ohio State University, Columbus, OH
The Role of the Healthcare Team in Biomarker Testing
Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT
Decoding Medicare for Healthcare Professionals
Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY
Treating Hodgkin Lymphoma: What HCPs Need to Know
Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA
Highlights from Attending the 2024 Society of Hematologic Oncology (SOHO) Annual Meeting
Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA
Unpacking Mantle Cell Lymphoma
Krish Patel, MD, Swedish Cancer Institute, Seattle, WA
Categories
- All Episodes (89)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (28)
- Genomics (3)
- Health Equity (7)
- Leukemia (21)
- Lymphoma (11)
- Minimal Residual Disease (MRD) (3)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (11)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
